EC approves imetelstat for transfusion-dependent anemia in lower-risk MDS
The European Commission (EC) has approved the marketing authorization for imetelstat (RYTELO), a first-in-class telomerase inhibitor, as a monotherapy for the treatment of
Myelodysplastic Syndromes
Lymphoma
T-Cell Lymphoma
Researchers document peripheral T-cell lymphomas across Latin America
A study documenting peripheral T-cell lymphoma epidemiology across Latin America found a high prevalence of adult T-cell leukemia or lymphoma and extranodal natural
Cellular Therapy
News
How do lifestyle factors play a role in the response to CAR-T therapy?
Ketogenic diet-derived BHB can be provided as a dietary intervention to augment CAR-T function in multiple cancer models.
Acute Myeloid Leukemia
Leukemia
News
Olutasidenib plus azacitidine show ‘durable’ responses in relapsed or refractory IDH1-mutated AML
The combination of olutasidenib plus azacitidine produced “durable” responses in patients with relapsed or refractory mIDH1 acute myeloid leukemia (AML), according to a
Cellular Therapy
Lymphoma
News
Society Updates
SOHO Young Investigator Spotlight: Meet Megan Melody, MD
In every phase of my career while I’ve been training, I have been lucky to be mentored by the major movers and shakers
Acute Myeloid Leukemia
Leukemia
News
Lintuzumab-Ac225 plus CLAG-M shows promising efficacy in R/R AML
Lintuzumab-Ac225 plus CLAG-M yielded “deep and meaningful responses” in patients with relapsed/refractory acute myeloid leukemia (AML), according the results of a phase 1
MDS Roundtable
Roundtable Discussions
What is the patient journey for those undergoing blood transfusions?
In this roundtable discussion on anemia management in MDS, the panel discusses the journey of a patient undergoing blood transfusions.
MPN Roundtable
Roundtable Discussions
What is the RO6 model?
In this video clip, the panel discusses the RO6 model's ability to predict outcomes for patients treated with ruxolitinib, particularly identifying those who
MPN Roundtable
News
Roundtable Discussions
Are there MPN therapies that improve platelets?
In this video segment of the MPN roundtable, the panel addresses common misconceptions about pacritinib, clarifying that while it enables JAK inhibition in
MPN Roundtable
News
Roundtable Discussions
Where does luspatercept potentially fit in MPN/anemia treatment?
A roundtable discussion on anemia management in myeloproliferative neoplasms, featuring moderator John Mascarenhas, MD, Mount Sinai; Andrew Kuykendall, MD, Moffitt Cancer Center; and
